title: An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized.
authors.affiliation: Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark.
authors.forename: Pınar
authors.initials: P
authors.lastname: Uysal
authors.affiliation: Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark.
authors.forename: Esben
authors.initials: E
authors.lastname: Eller
authors.affiliation: Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark.
authors.forename: Charlotte G
authors.initials: CG
authors.lastname: Mortz
authors.affiliation: Department of Dermatology and Allergy Centre, Odense Research Center for Anaphylaxis, Odense University Hospital, University of Southern Denmark, DK-5000 Odense C, Denmark. Electronic address: carsten.bindslev-Jensen@rsyd.dk.
authors.forename: Carsten
authors.initials: C
authors.lastname: Bindslev-Jensen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000465:Algorithms; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002648:Child; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D013997:Time Factors; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab